CoChat

Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk

Bays, Harold, Rodbard, Helena W., Schorr, Alan Bruce, González-Campoy, J. Michael · 2007 · Current Treatment Options in Cardiovascular Medicine

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Excessive adipose tissue is potentially pathogenic due to its mass effects and through adverse metabolic/immune responses, which may lead to cardiovascular disease risk factors (eg, type 2 diabetes mellitus, hypertension, dyslipidemia, and possibly atherosclerosis itself). Positive caloric balance in genetically/environmentally susceptible patients may result in adipocyte hypertrophy, visceral adipose tissue accumulation, and ectopic fat deposition, all causally associated with metabolic disease, and all anatomic manifestations of "adiposopathy" (a term used to describe adipose tissue pathology). Weight loss through improved nutrition, increased physical activity, and weight loss agents (ie, orlistat and sibutramine) improves adiposopathy and improves many metabolic diseases whose prevalence are directly associated with an increase in body fat and sedentary lifestyle. Cannabinoid receptor antagonists improve adiposopathy through weight reduction and favorable metabolic effects upon multiple body organs (including adipocytes). Peroxisome proliferator-activated receptor-gamma agonists may improve adiposopathy through recruitment of functional fat cells and apoptosis of dysfunctional fat cells.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11936-007-0021-6

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 4

  1. Bays H: Adiposopathy: defining, diagnosing, and establishing indications to treat “sick fat”: what are the regulatory considerations? US Endocrine Disease 2006, 2:12–14.
  2. Bays H: Adiposopathy: the endocannabinoid system as a therapeutic treatment target for dysfunctional “sick” fat. California J Health System Pharmacy 2007, 19:32–39.
  3. Genaer a Press Release: Genaera Corporation Announces Presentation of Data on Trodusquemine Mechanism of Action in Obesity. Available at http://www.genaera.com/press_room.php?page=134 . Accessed January 16, 2007.
  4. John-Soway J: Implications of Viewing Obesity as a Disease. Available at http://www.ama-assn.org/ama/pub/category/15630.html . Accessed February 28, 2007.

Cited by

See all 36

Metadata

Authors
Bays, H., Rodbard, H. W., Schorr, A. B., & González-Campoy, J. M.
Affiliations
Louisville Metabolic and Atherosclerosis Research Center (US)
Corresponding author
Bays, Harold
Venue
Current Treatment Options in Cardiovascular Medicine
Published
2007-07-09
Volume
9
Issue
4
Pages
259-271
ISSN
  • 1092-8464 (ISSN-L)
  • 1534-3189
OpenAlex
W2075718586
Cited by
36
References
49
Citations by year
2022: 1 · 2021: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 1 · 2014: 5 · 2013: 1 · 2012: 6
FWCI
3.03
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Treatment Options in Cardiovascular Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
adiposopathy, adipose tissue, cardiovascular risk, type 2 diabetes, hypertension, dyslipidemia, atherosclerosis, visceral adipose tissue, ectopic fat deposition, adipocyte hypertrophy, energy balance, weight loss, orlistat, sibutramine, cannabinoid receptor antagonists, peroxisome proliferator-activated receptor gamma agonists, adipocyte apoptosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk. https://app.cochat.ai/papers/10.1007/s11936-007-0021-6
The paper
Bays, H., Rodbard, H. W., Schorr, A. B., & González-Campoy, J. M. (2007). Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk. Current Treatment Options in Cardiovascular Medicine. https://doi.org/10.1007/s11936-007-0021-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.